SMA Type 1 Patients May Be at Greater Risk of Kidney Dysfunction, Study Finds
People with spinal muscular atrophy (SMA) type 1 may have an increased risk of impaired kidney function, a small…
Articles by Marta Figueiredo, PhD
Neural Stem Cell Transplants May Delay Progression of SMARD1, Animal Study Suggests
Transplanting a subset of neural stem cells (NSCs) to the spinal canal may be a potential therapy to delay disease…
Severity of Motor Problems at Diagnosis Helps to Predict Progression in SMA Type 2, Study Says
The severity of motor problems in children at the time of diagnosis with spinal muscular atrophy (SMA) type 2 may help…
Scholar Rock Announces Additional Preclinical Data Supporting SRK-015 as Potential SMA Treatment
Scholar Rock has announced the publication of new preclinical data supporting the potential therapeutic value of its experimental candidate therapy,…
Robotic Arm Controlled by Electrical Impulses Can Help SMA Patients Perform Daily Tasks
The use of a robotic arm controlled by electrical impulses in the arm muscles may increase the independence of paralyzed…
Researchers Develop Blood Test to Screen Newborns for SMA and Identify Carriers
Researchers have developed a rapid, specific blood test to screen newborns for spinal muscular atrophy (SMA) and identify carriers —…
Coordinators Are Key to Successful Family-centered Care for Kids with Type 1 SMA
Establishing care coordinators is key to providing successful family-centered care to young spinal muscular atrophy (SMA) type 1 patients and…
Standard Anesthesia for Spinraza Administration Safe, Effective in Children with Type 2 SMA, Study Shows
Standard general anesthesia for the administration of Spinraza (nusinersen) is safe and effective in children with type 2 spinal…
Spinraza Retards Disease Progression in Pre-symptomatic SMA Infants, Interim Results of Phase 2 Study Show
Biogen’s Spinraza (nusinersen) retards disease progression in pre-symptomatic spinal muscular atrophy (SMA) infants, allowing them to achieve motor…
Risdiplam May Halt Motor Impairment in SMA Patients, Interim Clinical Data Suggests
The investigational treatment risdiplam (RG7916) improved motor function in patients with type 1, 2 or 3 spinal…